首页> 外文期刊>Radiology >Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy.
【24h】

Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy.

机译:在美国指导的14针芯针活检中诊断为无异型的良性乳头状瘤:临床和美国特征可预示其将升级为恶性肿瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the diagnostic accuracy of ultrasonographically (US)-guided 14-gauge core-needle biopsy (CNB) for benign papilloma without atypia and to determine whether clinical and radiologic features could be used to predict an upgrade to malignancy. MATERIALS AND METHODS: This was an institutional review board-approved retrospective study, with a waiver of informed consent. The histologic results of US-guided CNB procedures performed from January 2006 through January 2009 were reviewed. A total of 160 benign papillomas without atypia that were diagnosed at CNB and excised surgically in 143 women (age range, 19-77 years) were assessed. Medical records and sonograms in the women were reviewed. Two radiologists working in consensus correlated imaging findings with the biopsy result to determine concordance. For the upgrade to malignancy after excision, malignant lesions were compared with nonmalignant lesions for the collected clinical and radiologic variables, which included patient age, lesion size, and lesion distance from the nipple, by using the chi(2) or Fisher exact test for categoric variables and the Mann-Whitney U test for continuous variables. RESULTS: Eight (5.0%) of 160 papillomas were upgraded to malignancy. Lesions that were 1 cm or larger (seven [11%] of 63) showed a higher upgrade rate than lesions that were smaller than 1 cm (one [1%] of 97) (P = .006). The upgrade rate was higher in patients aged 50 years or older (six [16%] of 37) than in patients younger than 50 years (two [2%] of 123) (P = .002). Lesions that were 3 cm or farther from the nipple (four [13%] of 31) showed a higher upgrade rate than lesions that were less than 3 cm from the nipple (four [3.1%] of 129) (P = .046). Upgrade rates for Breast Imaging Reporting and Data System (BI-RADS) category 3, 4a, 4b, 4c, and 5 lesions were 0%, 2.5%, 6%, 27%, and 25%, respectively (P = .010). CONCLUSION: At US-guided 14-gauge CNB, benign papilloma without atypia could be diagnosed accurately. Discordance between imaging and pathology results, as well as patient age of 50 years or older, lesion size of 1 cm or greater, lesion distance from the nipple of 3 cm or greater, and BI-RADS category may be helpful in predicting the possibility of upgrade to malignancy.
机译:目的:评估超声(美国)引导的14针芯针活检(CNB)对无异型性良性乳头状瘤的诊断准确性,并确定临床和放射学特征是否可用于预测恶性肿瘤的升级。材料与方法:这是一项经过机构审查委员会批准的回顾性研究,无需知情同意。回顾了2006年1月至2009年1月在美国指导下进行的CNB手术的组织学结果。共评估了160例在CNB被诊断为非典型性的良性乳头状瘤,并通过手术切除了143名女性(年龄范围为19-77岁)。回顾了妇女的病历和超声检查。两位一致同意的放射科医生将影像学检查结果与活检结果相关联以确定一致性。为了在切除后升级为恶性肿瘤,将恶性病变与非恶性病变进行比较,以收集的临床和放射学变量,包括使用chi(2)或Fisher精确检验对患者的年龄,病变大小和距乳头的病变距离进行比较。分类变量和Mann-Whitney U检验是否包含连续变量。结果:160例乳头状瘤中有8例(5.0%)升级为恶性肿瘤。 1厘米或更大的病变(63个中的7个[11%])显示的升级率高于小于1厘米(97个中的1个[1%])的病变升级率(P = .006)。 50岁或以上的患者(37岁中的六个[16%])的升级率高于50岁以下的患者(123个中的两个[2%])的升级率(P = .002)。距乳头3厘米或更远的病变(占31个中的四个[13%])显示出比小于乳头3 cm以下的病变(129个中的四个[3.1%])更高的升级率(P = .046) 。乳房影像报告和数据系统(BI-RADS)类别3、4a,4b,4c和5个病变的升级率分别为0%,2.5%,6%,27%和25%(P = .010) 。结论:在美国指导的14号CNB中,可以准确诊断出无异型的良性乳头状瘤。影像学和病理结果之间的不一致,以及患者年龄在50岁以上,病灶尺寸为1 cm或更大,距乳头的病灶距离为3 cm或更大,以及BI-RADS类别可能有助于预测患病的可能性升级为恶性肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号